Efficacy and safety of freeze-dried cat's claw in osteoarthritis of the knee:: mechanisms of action of the species Uncaria guianensis

被引:88
作者
Piscoya, J
Rodriguez, Z
Bustamante, SA
Okuhama, NN
Miller, MJS
Sandoval, M
机构
[1] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA
[2] Univ Nacl Mayor San Marcos, Fac Med, Lima 14, Peru
[3] Rainforest Phytoceut LLC, Delmar, NY USA
关键词
inflammation; TNF alpha; antioxidant; prostaglandin; complimentary medicine;
D O I
10.1007/PL00000268
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aim: The purpose of this investigation was to evaluate the ability of cat's claw, an Amazonian medicinal plant, to treat osteoarthritis of the knee, collect safety and tolerance information and compare the antioxidant, and anti-inflammatory actions of Uncaria guianensis and Uncaria tomentosa in vitro. Materials and methods: Forty-five patients with osteoarthritis of the knee were recruited, 30 were treated with freeze-dried U. guianensis, and 15 with placebo. Hematological parameters were assessed on entry and exit of the four-week trial. Pain, medical and subject assessment scores and adverse effects were collected at weeks 1, 2 and 4. The antioxidant and anti-inflammatory activity of the cat's claw species was determined by the alpha,alpha -diphenyl-beta -picrylhydrazyl (DPPH) free radical scavenging method. Inhibition of TNF alpha and prostaglandin E-2 (PGE(2)) production was determined in RAW 264.7 cells by ELISA. Results: Cat's claw had no deleterious effects on blood or liver function or other significant side-effects compared to placebo. Pain associated with activity, medical and patient assessment scores were all significantly reduced, with benefits occurring within the first week of therapy. Knee pain at rest or at night, and knee circumference were not significantly reduced by cat's claw during this brief trial. In vitro tests indicated that U. guianensis and U tomentosa were equivalent at quenching DPPH radicals (EC50, 13.6-21.7 mug/ml) as well as inhibiting TNF alpha production. However, the latter action was registered at much lower concentrations (EC50, 10.2-10.9 ng/ml). Cat's claw (10 mug/ml) had no effect on basal PGE(2) production, but reduced LPS-induced PGE(2) release (P < 0.05), but at higher concentrations than that required for TNF alpha inhibition. Conclusion: Cat's claw is an effective treatment for osteoarthritis. The species, U. guianensis and U. tomentosa are equiactive. They are effective antioxidants, but their antiinflammatory properties may result from their ability to inhibit TNF alpha and to a lesser extent PGE(2) production.
引用
收藏
页码:442 / 448
页数:7
相关论文
共 45 条
[1]   DEVELOPMENT OF CRITERIA FOR THE CLASSIFICATION AND REPORTING OF OSTEOARTHRITIS - CLASSIFICATION OF OSTEOARTHRITIS OF THE KNEE [J].
ALTMAN, R ;
ASCH, E ;
BLOCH, D ;
BOLE, G ;
BORENSTEIN, D ;
BRANDT, K ;
CHRISTY, W ;
COOKE, TD ;
GREENWALD, R ;
HOCHBERG, M ;
HOWELL, D ;
KAPLAN, D ;
KOOPMAN, W ;
LONGLEY, S ;
MANKIN, H ;
MCSHANE, DJ ;
MEDSGER, T ;
MEENAN, R ;
MIKKELSEN, W ;
MOSKOWITZ, R ;
MURPHY, W ;
ROTHSCHILD, B ;
SEGAL, M ;
SOKOLOFF, L ;
WOLFE, F .
ARTHRITIS AND RHEUMATISM, 1986, 29 (08) :1039-1049
[2]  
Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905
[3]   Induction of tumor necrosis factor alpha and interleukin-8 gene expression in bronchial epithelial cells by toxic shock syndrome toxin 1 [J].
Aubert, V ;
Schneeberger, D ;
Sauty, A ;
Winter, J ;
Sperisen, P ;
Aubert, JD ;
Spertini, F .
INFECTION AND IMMUNITY, 2000, 68 (01) :120-124
[4]   OUTCOME MEASUREMENT IN OSTEOARTHRITIS CLINICAL-TRIALS - THE CASE FOR STANDARDIZATION [J].
BELLAMY, N ;
BUCHANAN, WW .
CLINICAL RHEUMATOLOGY, 1984, 3 (03) :293-303
[5]  
BERRY H, 1982, CLIN TRIALS, V37, P259
[6]  
Burtis C., 1999, TIETZ TXB CLIN CHEM
[7]  
Charles P, 1999, J IMMUNOL, V163, P1521
[8]  
Coggon D, 2000, ARTHRITIS RHEUM, V43, P1443, DOI 10.1002/1529-0131(200007)43:7<1443::AID-ANR5>3.0.CO
[9]  
2-1
[10]   AN ARTICULAR INDEX FOR THE ASSESSMENT OF OSTEO-ARTHRITIS [J].
DOYLE, DV ;
DIEPPE, PA ;
SCOTT, J ;
HUSKISSON, EC .
ANNALS OF THE RHEUMATIC DISEASES, 1981, 40 (01) :75-78